Healthpeak Properties, Inc. (NYSE:DOC) Receives $23.83 Consensus PT from Analysts

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) has been given an average rating of "Moderate Buy" by the twelve analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $23.45.

A number of analysts have commented on the stock. Evercore ISI cut their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday. Scotiabank cut their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. Morgan Stanley upgraded shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. Robert W. Baird cut their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Tuesday, February 11th. Finally, Wedbush cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 11,337 shares of the firm's stock in a transaction on Monday, April 28th. The stock was bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the transaction, the chief executive officer now directly owns 201,863 shares of the company's stock, valued at approximately $3,568,937.84. This represents a 5.95 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John T. Thomas purchased 4,200 shares of the firm's stock in a transaction on Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the transaction, the director now directly owns 813,566 shares in the company, valued at $14,514,017.44. This trade represents a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.23% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its position in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after buying an additional 4,056,931 shares during the period. Diamant Asset Management Inc. purchased a new position in Healthpeak Properties in the third quarter valued at $564,000. Vert Asset Management LLC raised its stake in Healthpeak Properties by 11.1% in the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust's stock valued at $6,167,000 after buying an additional 30,461 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in Healthpeak Properties by 25.7% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust's stock worth $2,213,000 after buying an additional 22,300 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Healthpeak Properties by 16.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust's stock worth $2,217,000 after acquiring an additional 15,753 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Price Performance

DOC stock traded down $0.06 during mid-day trading on Wednesday, reaching $17.77. The company's stock had a trading volume of 6,623,695 shares, compared to its average volume of 4,911,239. The stock has a market cap of $12.43 billion, a PE ratio of 50.77, a P/E/G ratio of 2.17 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties has a fifty-two week low of $17.33 and a fifty-two week high of $23.26. The company's 50 day moving average is $19.53 and its two-hundred day moving average is $20.53.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. Healthpeak Properties's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.45 EPS. Equities research analysts expect that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, April 30th. Investors of record on Friday, April 18th will be given a dividend of $0.1017 per share. The ex-dividend date is Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties's payout ratio is currently 305.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.